BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16984387)

  • 1. Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method.
    Chen IM; Chakerian A; Devidas M; Borowitz MJ; Hunger SP; Willman CL; Viswanatha DS
    Br J Haematol; 2006 Nov; 135(3):358-61. PubMed ID: 16984387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time quantification of TEL-AML1 fusion transcripts for MRD detection in relapsed childhood acute lymphoblastic leukaemia. Comparison with antigen receptor-based MRD quantification methods.
    Taube T; Eckert C; Körner G; Henze G; Seeger K
    Leuk Res; 2004 Jul; 28(7):699-706. PubMed ID: 15158091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.
    von Goessel H; Jacobs U; Semper S; Krumbholz M; Langer T; Keller T; Schrauder A; van der Velden VH; van Dongen JJ; Harbott J; Panzer-Grümayer ER; Schrappe M; Rascher W; Metzler M
    Leuk Res; 2009 Aug; 33(8):1082-8. PubMed ID: 19081626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
    László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
    Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated detection of residual leukemic cells by consecutive immunolabeling for CD10 and fluorescence in situ hybridization for ETV6/RUNX1 rearrangement in childhood acute lymphoblastic leukemia.
    Alpár D; Kajtár B; Kneif M; Jáksó P; László R; Kereskai L; Pajor L
    Cancer Genet Cytogenet; 2007 Feb; 173(1):23-30. PubMed ID: 17284366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
    Tiensiwakul P
    Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group.
    Sedlácek P; Trka J; Zuna J; Hrusák O; Honzátková-Krsková L; Stary J
    Haematologica; 2000 Oct; 85(10):1100-2. PubMed ID: 11025608
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
    Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
    Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia.
    Robillard N; Cavé H; Méchinaud F; Guidal C; Garnache-Ottou F; Rohrlich PS; Avet-Loiseau H; Garand R
    Haematologica; 2005 Nov; 90(11):1516-23. PubMed ID: 16266899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-existence of multiple subclones in TEL-AML1 at diagnosis of acute lymphoblastic leukaemia in association with submicroscopic deletion of AML1.
    Rothman R; Trakhtenbrot L; Bielorai B; Izraeli S; Ishoev G; Amariglio N; Rechavi G; Toren A
    Br J Haematol; 2005 May; 129(4):491-8. PubMed ID: 15877731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL-AML1 frequency in multi-ethnic Malaysian pediatric acute lymphoblastic leukemia.
    Gill HK; Keoh TS; Dhaliwal JS; Moore S; Kim TS; Hassan R; Karim FA; Zakaria Z; Murad S; Mohamed M; Li Ho CM; Ibrahim H; Rahman EJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):129-33. PubMed ID: 15642392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of prognostically important childhood acute lymphoblastic leukemia chimeric transcripts using multiplex SYBR green real-time reverse transcription PCR.
    Ibrahim K; Daud SS; Seah YL; Yeoh AE; Ariffin H;
    Ann Clin Lab Sci; 2008; 38(4):338-43. PubMed ID: 18988926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis.
    Ly-Sunnaram B; Henry C; Gandemer V; Mee FL; Burtin F; Blayau M; Cayuela JM; Oster M; Clech P; Rambeau M; Marie C; Pampin C; Edan C; Gall EL; Goasguen JE
    Leuk Res; 2005 Sep; 29(9):1089-94. PubMed ID: 16038737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL.
    Soszynska K; Mucha B; Debski R; Skonieczka K; Duszenko E; Koltan A; Wysocki M; Haus O
    Ann Hematol; 2008 Dec; 87(12):991-1002. PubMed ID: 18633615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.